Navigation Links
Neuronascent to Present at Life Sciences Summit 2009
Date:9/15/2009

CLARKSVILLE, Md.., Sept. 15 /PRNewswire/ -- Neuronascent, Inc., a privately-held biotechnology company developing novel, neurogenic small-molecule drugs for the treatment of depression, Alzheimer's, Parkinson's and other neurodegenerative diseases, today announced that Dr. Judith Kelleher-Andersson, President and Chief Scientific Officer, will present at the Life Sciences Summit 2009 -- Showcasing Innovation, Promoting Collaboration. The Summit brings the world's leading companies together with the world's most innovative scientists to explore the next generation of biomedical solutions, the proceeds from which will help seed a bio-innovation research fund to support the discovery, development, translation, and commercialization of these new technologies. The event will take place on September 23-24, 2009 at Hyatt Regency Long Island in Hauppauge, New York.

"We are proud to have been selected to showcase the potential of our first-in-class CNS drug candidates and our neurogenesis platform," said Dr. Kelleher-Andersson. "Our participation in the Summit, with the nation's leading research institutions and top bioscience companies, supports our strategy for collaboration and innovation combining the best of business and the best of science."

About Neuronascent, Inc.:

Founded in 2004 by Dr. Judith Kelleher-Andersson, Neuronascent, discovers and develops first-in-class, small-molecule therapeutics, based on the science of neurogenesis, that target depression and neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The Company is headquartered in Clarksville, MD and has facilities in Rockville and Walkersville, MD. For additional information, please visit www.neuronascent.com.

About The Center for Biotechnology, A New York State Center for Advanced Technology in Medical Biotechnology:

The Center for Biotechnology is a cooperative research and development partnership between universities, private industry and New York State. Located on the campus of Stony Brook University, the Center's technology development initiative has contributed to an active pipeline of more than forty commercially promising technologies, the commercialization of more than a dozen novel biomedical products, and the formation of eighteen new bioscience companies. The Center is funded by the New York Office of Science, Technology and Academic Research (NYSTAR). Visit www.biotech.sunysb.edu for more information on the Center.


'/>"/>
SOURCE Neuronascent, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Martek to Present at Two Upcoming Investor Conferences
2. ViroPharma to Present at Four Additional Healthcare Conferences
3. Regado Biosciences to Present at the BioPharm America 2009 Conference on September 17, 2009
4. ERT to Present at UBS Global Life Sciences Conference on September 21, 2009
5. Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference
6. NovaBay(R) Presents Data Confirming Its Aganocide(R) Compounds Are Effective In Killing Bacteria That Have Developed Multidrug-Resistance
7. aTyr Pharma to Present at BioPharm America 2009
8. CryoLife to Present at UBS Global Life Sciences Conference
9. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting
10. Amgen to Present at the Morgan Stanley Global Healthcare Unplugged Conference
11. Enox Biopharma Will Present Its Unique Self-Sterilizing Urinary Catheter at the 49th Annual ICAAC Meeting.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... BioAmber Inc. (NYSE: BIOA ) announced today that Jean-Francois Huc ... company,s COO, has been named President, effective immediately.  ... has overseen the construction, start-up and operation of the manufacturing plant ... Mitsui JV.  Fabrice has also been extensively involved in the negotiations ... ...
(Date:2/20/2017)... ... February 20, 2017 , ... ... teleradiology and telemedicine company announces at HIMSS 2017 Annual Conference (Orlando, FL) ... be offered via a global cloud-based sharing and collaboration platform as part ...
(Date:2/20/2017)...  Atrius Health and IBM (NYSE: IBM ... to develop a cloud based service designed to ... view of the multiple influences on an individual,s ... be designed to support shared decision making between ... nonprofit healthcare organization with 875 physicians caring for ...
(Date:2/18/2017)... Feb 17, 2017 Research and Markets has ... Report" report to their offering. ... The report provides separate comprehensive analytics for ... , and Rest of World. Annual estimates and forecasts are provided ... is provided for these markets. Market data and analytics are derived ...
Breaking Biology Technology:
(Date:2/16/2017)... , Feb. 16, 2017  Genos, a ... announced that it has received Laboratory Accreditation from ... Accreditation is presented to laboratories that meet stringent ... demonstrate scientifically rigorous processes. "Genos is ... in laboratory practices. We,re honored to be receiving ...
(Date:2/9/2017)... Feb. 9, 2017 The biomass boiler market ... the biomass boiler market globally in terms of revenue ... boilers. The market for biomass boilers has been segmented ... application, and country/region. The market based on feedstock type, ... residues, biogas & energy crops, urban residues, and others. ...
(Date:2/8/2017)... Report Highlights The global biosurgery market should ... 2016 at a compound annual growth rate (CAGR) of ... An overview of the global market for biosurgery. - ... and 2016, and projections of compound annual growth rates ... the basis of product type, source, application, and region. ...
Breaking Biology News(10 mins):